{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:07:28Z","timestamp":1791608848002,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05250-w","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T07:03:12Z","timestamp":1669186992000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum levels of interleukin 17 and 22 in patients with systemic sclerosis: a single-center cross-sectional study"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6220-3685","authenticated-orcid":false,"given":"\u017deljka","family":"Kardum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5574-833X","authenticated-orcid":false,"given":"Jasminka","family":"Milas-Ahi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8841-8871","authenticated-orcid":false,"given":"Ines","family":"\u0160ahinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6687-8500","authenticated-orcid":false,"given":"Ana Marija","family":"Masle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9063-1433","authenticated-orcid":false,"given":"Dora","family":"Ur\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-6206","authenticated-orcid":false,"given":"Martina","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"5","key":"5250_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102515","volume":"19","author":"RL Smeets","year":"2020","unstructured":"Smeets RL, Kersten BE, Joosten I et al (2020) Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels. Autoimmun Rev 19(5):102515. https:\/\/doi.org\/10.1016\/j.autrev.2020.102515","journal-title":"Autoimmun Rev"},{"key":"5250_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-021-08889-8","volume":"2021","author":"ME Truchetet","year":"2021","unstructured":"Truchetet ME, Brembilla NC, Chizzolini C (2021) Current concepts on the pathogenesis of systemic sclerosis. Clin Rev Allergy Immunol 2021:1\u201322. https:\/\/doi.org\/10.1007\/s12016-021-08889-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"5250_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.imlet.2018.01.002","volume":"195","author":"A Yoshizaki","year":"2018","unstructured":"Yoshizaki A (2018) Pathogenic roles of B lymphocytes in systemic sclerosis. Immunol Lett 195:76\u201382. https:\/\/doi.org\/10.1016\/j.imlet.2018.01.002","journal-title":"Immunol Lett"},{"issue":"7","key":"5250_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","volume":"15","author":"M Cutolo","year":"2019","unstructured":"Cutolo M, Soldano S, Smith V (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Rev Clin Immunol 15(7):753\u2013764. https:\/\/doi.org\/10.1080\/1744666X.2019.1614915","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"5250_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cei.13238","volume":"195","author":"M Brown","year":"2019","unstructured":"Brown M, O\u2019Reilly S (2019) The immunopathogenesis of fibrosis in systemic sclerosis. Clin Exp Immunol 195(3):310\u2013321. https:\/\/doi.org\/10.1111\/cei.13238","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"5250_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/ard.2010.133587","volume":"70","author":"TC Barnes","year":"2011","unstructured":"Barnes TC, Spiller DG, Anderson ME, Edwards SW, Moots RJ (2011) Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis 70(2):366\u2013372. https:\/\/doi.org\/10.1136\/ard.2010.133587","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5250_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08916934.2017.1416467","volume":"51","author":"RSG Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves RSG, Pereira MC, Dantas AT et al (2018) IL-17 and related cytokines involved in systemic sclerosis: perspectives. Autoimmunity 51(1):1\u20139. https:\/\/doi.org\/10.1080\/08916934.2017.1416467","journal-title":"Autoimmunity"},{"issue":"5","key":"5250_CR8","first-page":"14","volume":"34","author":"L Lei","year":"2016","unstructured":"Lei L, Zhao C, Qin F, He ZY, Wang X, Zhong XN (2016) Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol 34(5):14\u201322","journal-title":"Clin Exp Rheumatol"},{"key":"5250_CR9","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3389\/fimmu.2018.01611","volume":"9","author":"MJ Park","year":"2018","unstructured":"Park MJ, Moon SJ, Lee EJ et al (2018) IL-1-IL-17 signaling axis contributes to fibrosis and inflammation in two different murine models of systemic sclerosis. Front Immunol 9:1611. https:\/\/doi.org\/10.3389\/fimmu.2018.01611","journal-title":"Front Immunol"},{"issue":"5","key":"5250_CR10","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/ar4334","volume":"15","author":"NC Brembilla","year":"2013","unstructured":"Brembilla NC, Montanari E, Truchetet ME, Raschi E, Meroni P, Chizzolini C (2013) Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts. Arthritis Res Ther 15(5):R151. https:\/\/doi.org\/10.1186\/ar4334","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5250_CR11","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/ar4430","volume":"16","author":"X Yang","year":"2014","unstructured":"Yang X, Yang J, Xing X, Wan L, Li M (2014) Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction. Arthritis Res Ther 16(1):R4. https:\/\/doi.org\/10.1186\/ar4430","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"5250_CR12","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","volume":"188","author":"T Nakashima","year":"2012","unstructured":"Nakashima T, Jinnin M, Yamane K et al (2012) Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. J Immunol 188(8):3573\u20133583. https:\/\/doi.org\/10.4049\/jimmunol.1100591","journal-title":"J Immunol"},{"key":"5250_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2020.00220","volume":"11","author":"S Vettori","year":"2020","unstructured":"Vettori S, Barra G, Russo B et al (2020) T-Cell proapoptotic and antifibrotic activity against autologous skin fibroblasts in vitro is associated with IL-17A axis upregulation in systemic sclerosis. Front Immunol 11:220. https:\/\/doi.org\/10.3389\/fimmu.2020.00220","journal-title":"Front Immunol"},{"issue":"1","key":"5250_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","volume":"140","author":"AM Dufour","year":"2020","unstructured":"Dufour AM, Borowczyk-Michalowska J, Alvarez M et al (2020) IL-17A dissociates inflammation from fibrogenesis in systemic sclerosis. J Invest Dermatol 140(1):103-112.e8. https:\/\/doi.org\/10.1016\/j.jid.2019.05.026","journal-title":"J Invest Dermatol"},{"issue":"11","key":"5250_CR15","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","volume":"43","author":"K Kurasawa","year":"2000","unstructured":"Kurasawa K, Hirose K, Sano H et al (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43(11):2455\u20132463. https:\/\/doi.org\/10.1002\/1529-0131(200011)43:11%3c2455::AID-ANR12%3e3.0.CO;2-K","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5250_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","volume":"50","author":"M Murata","year":"2008","unstructured":"Murata M, Fujimoto M, Matsushita T et al (2008) Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease? J Dermatol Sci 50(3):240\u2013242. https:\/\/doi.org\/10.1016\/j.jdermsci.2008.01.001","journal-title":"J Dermatol Sci"},{"issue":"6","key":"5250_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005903","volume":"4","author":"TR Radstake","year":"2009","unstructured":"Radstake TR, van Bon L, Broen J et al (2009) The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS\u00a0One 4(6):e5903. https:\/\/doi.org\/10.1371\/journal.pone.0005903","journal-title":"PLoS\u00a0One"},{"issue":"5","key":"5250_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/jid.2012.463","volume":"133","author":"HM McGee","year":"2013","unstructured":"McGee HM, Schmidt BA, Booth CJ et al (2013) IL-22 promotes fibroblast-mediated wound repair in the skin. J Invest Dermatol 133(5):1321\u20131329. https:\/\/doi.org\/10.1038\/jid.2012.463","journal-title":"J Invest Dermatol"},{"issue":"7","key":"5250_CR19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/annrheumdis-2011-200709","volume":"71","author":"A Mathian","year":"2012","unstructured":"Mathian A, Parizot C, Dorgham K et al (2012) Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions. Ann Rheum Dis 71(7):1227\u20131234. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200709","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5250_CR20","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar3486","volume":"13","author":"ME Truchetet","year":"2011","unstructured":"Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C (2011) Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 13(5):R166. https:\/\/doi.org\/10.1186\/ar3486","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"5250_CR21","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/annrheumdis-2015-207477","volume":"75","author":"NC Brembilla","year":"2016","unstructured":"Brembilla NC, Dufour AM, Alvarez M et al (2016) IL-22 capacitates dermal fibroblast responses to TNF in scleroderma. Ann Rheum Dis 75(9):1697\u20131705. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207477","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5250_CR22","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72(11):1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5250_CR23","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J et al (1995) (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281\u20131285","journal-title":"J Rheumatol"},{"issue":"3","key":"5250_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102458","volume":"19","author":"V Smith","year":"2020","unstructured":"Smith V, Herrick AL, Ingegnoli F et al (2020) Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2019s phenomenon and systemic sclerosis. Autoimmun Rev 19(3):102458. https:\/\/doi.org\/10.1016\/j.autrev.2020.102458","journal-title":"Autoimmun Rev"},{"issue":"2","key":"5250_CR25","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"issue":"3","key":"5250_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.5114\/aoms.2019.84738","volume":"15","author":"E Robak","year":"2019","unstructured":"Robak E, Gerlicz-Kowalczuk Z, Dziankowska-Bartkowiak B, Wozniacka A, Bogaczewicz J (2019) Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis. Arch Med Sci 15(3):706\u2013712. https:\/\/doi.org\/10.5114\/aoms.2019.84738","journal-title":"Arch Med Sci"},{"issue":"1","key":"5250_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1515\/rjim-2015-0006","volume":"53","author":"P B\u0103l\u0103nescu","year":"2015","unstructured":"B\u0103l\u0103nescu P, L\u0103daru A, B\u0103l\u0103nescu E, Nicolau A, B\u0103icu\u015f C, Dan GA (2015) IL-17, IL-6 and IFN-\u03b3 in systemic sclerosis patients. Rom J Intern Med 53(1):44\u201349. https:\/\/doi.org\/10.1515\/rjim-2015-0006","journal-title":"Rom J Intern Med"},{"issue":"6","key":"5250_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000510048","volume":"87","author":"SS Batah","year":"2020","unstructured":"Batah SS, Alda MA, Rodrigues Lopes Roslindo Figueira R et al (2020) In situ evidence of collagen V and interleukin-6\/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension. Pathobiology 87(6):356\u2013366. https:\/\/doi.org\/10.1159\/000510048","journal-title":"Pathobiology"},{"issue":"12","key":"5250_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085032","volume":"8","author":"X Xing","year":"2013","unstructured":"Xing X, Yang J, Yang X et al (2013) IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway. PLoS\u00a0One 8(12):e85032. https:\/\/doi.org\/10.1371\/journal.pone.0085032","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"5250_CR30","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","volume":"16","author":"M Liu","year":"2014","unstructured":"Liu M, Yang J, Xing X, Cui X, Li M (2014) Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway. Arthritis Res Ther 16(6):4223. https:\/\/doi.org\/10.1186\/s13075-014-0512-2 (Published 2014 Dec 31)","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5250_CR31","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/10\/4\/046013","volume":"10","author":"G Rolla","year":"2016","unstructured":"Rolla G, Fusaro E, Nicola S et al (2016) Th-17 cytokines and interstitial lung involvement in systemic sclerosis. J Breath Res 10(4):046013. https:\/\/doi.org\/10.1088\/1752-7155\/10\/4\/046013","journal-title":"J Breath Res"},{"issue":"1","key":"5250_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jdermsci.2017.12.017","volume":"90","author":"S Sawamura","year":"2018","unstructured":"Sawamura S, Jinnin M, Inoue K et al (2018) Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts. J Dermatol Sci 90(1):52\u201359. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.017","journal-title":"J Dermatol Sci"},{"key":"5250_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/209179","volume":"8","author":"M Liang","year":"2013","unstructured":"Liang M, Wang J, Chu H et al (2013) (2013) Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis. Mediators Inflamm 8:209179. https:\/\/doi.org\/10.1155\/2013\/209179","journal-title":"Mediators Inflamm"},{"issue":"8","key":"5250_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.509","volume":"11","author":"P Gu","year":"2021","unstructured":"Gu P, Wang D, Zhang J et al (2021) Protective function of interleukin-22 in pulmonary fibrosis. Clin Transl Med 11(8):e509. https:\/\/doi.org\/10.1002\/ctm2.509","journal-title":"Clin Transl Med"},{"issue":"1","key":"5250_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","volume":"76","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Hou W, Xu K et al (2015) The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis. Hum Immunol 76(1):22\u201329. https:\/\/doi.org\/10.1016\/j.humimm.2014.12.008","journal-title":"Hum Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05250-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05250-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05250-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T08:07:14Z","timestamp":1675411634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05250-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["5250"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05250-w","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The authors fulfilled the ICMJE authorship criteria.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient prior to the submission of this article for consideration.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}